Eli Lilly, Sarepta, Pfizer, Medicare, Novo: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
3 N.J. children’s hospitals receive top marks from U.S. News
If you’re looking for a good children’s hospital, New Jersey is home to three of the nation’s best,…
Here Are 2 With Even More Upside Ahead
On Sept. 30, Pfizer announced a deal with the U.S. government that will allow the pharmaceutical leader to…
Amazon to start offering prescription drugs through vending machines
Amazon announced it is rolling out “pharmacy kiosks” beginning in December. The self-service kiosks will allow Amazon’s One…
Consultant: US insurer held accountable after $100m in AI cuts – The Royal Gazette
Created: Oct 08, 2025 08:00 AM Clayton Gillett, managing partner at Info-Tech, speaks to an audience of chief…
NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump | Pharmaceuticals industry
Ministers are preparing to raise the amount the NHS pays pharmaceutical firms for medicines by up to 25%…
Amazon Brings Prescriptions to Medical Offices via Kiosks
The tech giant is launching Amazon Pharmacy Kiosks, which will be placed in medical offices, allowing patients to pick…
CT hospital names new CEO amid ambitious, $320M expansion
A former top administrator at a Rhode Island hospital has been named president and chief executive officer at…
OneMedNet Partners With Palantir to Advance Next-Gen Healthcare Data Platform
This article first appeared on GuruFocus. OneMedNet (ONMD, Financials) has partnered with Palantir (PLTR, Financials) Technologies to strengthen…
Sandra spent every day living with pain from endometriosis until she went to London
There was a time when Cork woman Sandra Murphy spent every day living with pain. In fact, 18…
The Malpractice of Menopausal Medicine Reveals a Broken Medical System
Excerpted from the book GOING MENOPOSTAL: What You (and Your Doctor) Need to Know About the Real Science…
Coverage of Sarepta Duchenne drug may be halted by N.Y. state Medicaid
In a setback for Sarepta Therapeutics, a New York panel has voted unanimously to recommend the state Medicaid…